Placebo Effect

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118

In the pooled placebo arms (n=153), early improvement in anxiety-psychic (p=0.003, r2=0.110) and somatic symptoms-general (p=0.001, r2=0.118) items from baseline to week 1 significantly predicted remi

Effect: improvement; anxiety-psychic: p=0.003, r2=0.110; somatic-general: p=0.001, r2=0.118